Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway

Molecular Cancer Therapeutics
Deborah ChirnomasAlan D D'Andrea

Abstract

Cisplatin resistance occurs, at least in part, through the function of the Fanconi anemia (FA)/BRCA pathway, a DNA-damage response pathway required for repair of cisplatin cross-links. In the current study, we designed a cell-based screening strategy to identify small-molecule inhibitors of the FA/BRCA pathway with the hypothesis that such molecules could restore sensitivity to platinum agents. We identified four inhibitors, including three protein kinase inhibitors (wortmannin, H-9, and alsterpaullone) and one natural compound (curcumin) that inhibit the FA/BRCA pathway. We show that curcumin, a compound that is generally regarded as safe, inhibits the monoubiquitination of the FANCD2 protein as predicted by the screen and consequently sensitizes ovarian and breast tumor cell lines to cisplatin through apoptotic cell death. We believe that this study shows an efficient, high-throughput method for identifying new compounds that may sensitize cancer cells to DNA-damaging chemotherapy.

References

Jan 1, 1988·International Journal of Immunopharmacology·M ItoS Shigeta
Dec 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G W SledgeL H Einhorn
Oct 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D BajorinR Fein
Jun 1, 1982·American Journal of Clinical Oncology·A A ForastiereR E Wittes
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·D S OryR C Mulligan
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·Y CanitrotJ S Hoffmann
Mar 10, 2001·Molecular Cell·C TimmersM Grompe
Mar 10, 2001·Molecular Cell·I Garcia-HigueraA D D'Andrea
Oct 23, 2001·International Journal of Cancer. Journal International Du Cancer·D M ParkinP Pisani
Mar 22, 2002·The Lancet Oncology·D M Parkin
Jun 28, 2002·Cell·Toshiyasu TaniguchiAlan D D'Andrea
Nov 26, 2002·Nature Cell Biology·Koji NakanishiAlan D D'Andrea
Jan 2, 2003·Nature Reviews. Cancer·Alan D D'Andrea, Markus Grompe
Apr 5, 2003·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Nita Chainani-Wu
Apr 8, 2003·Current Medicinal Chemistry. Anti-cancer Agents·Tzeng-Horng Leu, Ming-Chei Maa
Apr 15, 2003·Nature Medicine·Toshiyasu TaniguchiAlan D D'Andrea
May 2, 2003·Nature Medicine·Grover C Bagby, Susan B Olson
Jun 5, 2003·Cancer Cell·Olufunmilayo I Olopade, Minjie Wei
Jul 2, 2003·Nature Reviews. Cancer·Roshan Agarwal, Stan B Kaye
Sep 16, 2003·Nature Genetics·Amom Ruhikanta MeeteiWeidong Wang
Jan 17, 2004·Cancer Biology & Therapy·Carmelle D RogersMichael Goggins
Apr 24, 2004·Science·Marie E EganMichael J Caplan
May 6, 2004·Cancer Research·Gopeshwar NarayanVundavalli V V S Murty
Jun 17, 2004·Molecular and Cellular Biology·XiaoZhe WangAlan D D'Andrea
Jul 28, 2004·The American Journal of Pathology·Michiel S van der HeijdenScott E Kern
Aug 18, 2004·Genes & Development·Paul R AndreassenToshiyasu Taniguchi
Aug 25, 2004·Cancer Cell·Gergely SzakácsMichael M Gottesman
Oct 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ricky A SharmaWilliam P Steward
Oct 27, 2004·Nature Genetics·Amom Ruhikanta MeeteiHans Joenje
Nov 18, 2004·American Journal of Obstetrics and Gynecology·Curtis BalchKenneth P Nephew
Mar 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anne Hamilton, Gabriel Hortobagyi
May 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Juliane HannemannMarc J van de Vijver
Aug 24, 2005·Nature Genetics·Marieke LevitusHans Joenje
Aug 24, 2005·Nature Genetics·Orna LevranArleen D Auerbach
Sep 1, 2005·Nature Genetics·Larry H Thompson

❮ Previous
Next ❯

Citations

Aug 24, 2010·Cellular and Molecular Life Sciences : CMLS·Angelo Guainazzi, Orlando D Schärer
Jan 16, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Clark C ChenAlan D'Andrea
Jan 28, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jessica N McAlpineC Blake Gilks
Sep 26, 2006·Oncogene·C G Mathew
May 21, 2010·The New England Journal of Medicine·Alan D D'Andrea
Aug 9, 2012·Antioxidants & Redox Signaling·Balachandran S VinodRuby John Anto
Feb 10, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H Calvert, A Azzariti
Nov 29, 2011·Clinical and Experimental Pharmacology & Physiology·Subash C GuptaBharat B Aggarwal
Nov 26, 2009·Cancer Research·Henri J van de VrugtMarkus Grompe
Apr 12, 2012·Molecular Cancer Therapeutics·Siqing FuRazelle Kurzrock
Jan 6, 2012·Molecular Cancer Research : MCR·Younghoon KeeAlan D D'Andrea
Apr 6, 2007·ORL; Journal for Oto-rhino-laryngology and Its Related Specialties·Volkert B WreesmannSteven J Wang
Mar 1, 2007·Blood·Tsukasa OdaTakayuki Yamashita
Dec 6, 2007·BMC Biochemistry·Céline Jacquemont, Toshiyasu Taniguchi
Apr 28, 2012·Molecular Cancer·Céline JacquemontToshiyasu Taniguchi
Jan 2, 2010·Molecular Cancer·Igor LandaisMaureen E Hoatlin
May 13, 2010·Breast Cancer Research : BCR·Bryan P Rowe, Peter M Glazer
Jan 19, 2012·PloS One·Weiya Z WyshamTanja Pejovic
Oct 21, 2011·International Journal of Molecular Medicine·Taskeen MujtabaQ Ping Dou
Nov 28, 2014·International Journal of Molecular Sciences·Katarzyna M TerlikowskaSlawomir J Terlikowski
Dec 26, 2006·Expert Review of Anticancer Therapy·Henry B Koon, Michael B Atkins
Sep 3, 2010·Critical Reviews in Biochemistry and Molecular Biology·Lily C Wang, Jean Gautier
Oct 29, 2015·The FEBS Journal·Jordi Carreras PuigvertThomas Helleday
Jan 19, 2016·Scientific Reports·Martin MistrikJiri Bartek
Oct 31, 2012·Pharmacology & Therapeutics·John M Furgason, El Mustapha Bahassi
Jun 12, 2012·Translational Research : the Journal of Laboratory and Clinical Medicine·Shane R Stecklein, Roy A Jensen
Apr 22, 2009·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Oluf Dimitri RøeSteinar Lundgren
May 26, 2009·Mutation Research·Kornelia NevelingDetlev Schindler
Jan 27, 2009·Gynecologic Oncology·Jennifer E QuinnD Paul Harkin
Dec 17, 2008·Clinical Breast Cancer·John G WestCaitlin Fanning
Sep 13, 2008·DNA Repair·Lily Chien WangJean Gautier
Jun 26, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Giovanna Damia, Maurizio D'Incalci
Jul 24, 2007·Cancer Letters·Alex Lyakhovich, Jordi Surralles
Dec 3, 2008·International Journal of Cancer. Journal International Du Cancer·Igor LandaisMaureen E Hoatlin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.